Company Filing History:
1 out of 5,104 
1 out of 266 
1 out of 4 Years Active: 2019
Title: Dante Rotili: Innovator in Cancer Treatment
Introduction
Dante Rotili is a notable inventor based in Rome, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in cancer treatment. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Dante Rotili holds a patent for "Substituted quinazoline derivatives as DNA methyltransferase inhibitors." This invention relates to compounds of a specific formula and their pharmaceutically acceptable salts and solvates. The patent outlines methods of preparation and emphasizes the use of these compounds as drugs, particularly in the treatment of cancer. This advancement has the potential to impact cancer therapies significantly.
Career Highlights
Throughout his career, Dante has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Pierre Fabre Medicament. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Dante has collaborated with notable colleagues, including Ludovic Halby and Paola Barbara Arimondo. These partnerships have enriched his research and expanded the scope of his work in the pharmaceutical industry.
Conclusion
Dante Rotili's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a significant figure in the field of pharmaceuticals. His work continues to inspire advancements in medical research and drug development.